Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 6181 AL 6195

Spinocerebellar ataxia type 11 (SCA11): TTBK2 variants, functions and associated disease mechanisms

Felício D, Santos M.

Cerebellum. 2024 Apr;23(2):678-687. doi: 10.1007/s12311-023-01540-6. Epub 2023 Mar 9.

Hereditary Ataxias: From Bench to Clinic, Where Do We Stand?

Pilotto F, Del Bondio A, Puccio H.

Cells. 2024 Feb 9;13(4):319. doi: 10.3390/cells13040319.

Ataxic hemiparesis: a narrative review for clinical practice in rehabilitation

Sung MF, Lim JH.

Top Stroke Rehabil. 2024 Jul;31(5):537-545. doi: 10.1080/10749357.2023.2281722. Epub 2023 Nov 15.

I(123)-FP-CIT (DaTSCAN) SPECT beyond the Most Common Causes of Parkinsonism: A Systematic Review

Quintas S, Sanles-Falagan R, Berbís MÁ.

Mov Disord Clin Pract. 2024 Jun;11(6):613-625. doi: 10.1002/mdc3.14055. Epub 2024 May 1.

Omaveloxolone: a groundbreaking milestone as the first FDA-approved drug for Friedreich ataxia

Pilotto F, Chellapandi DM, Puccio H.

Trends Mol Med. 2024 Feb;30(2):117-125. doi: 10.1016/j.molmed.2023.12.002. Epub 2024 Jan 24.

Effects of Non-Invasive Brain Stimulation for Degenerative Cerebellar Ataxia: A Systematic Review and Meta-Analysis

Matsugi A, Ohtsuka H, Bando K, Kondo Y, Kikuchi Y.

Mov Disord Clin Pract. 2024 Nov;11(11):1323-1334. doi: 10.1002/mdc3.14205. Epub 2024 Sep 2.

Autoimmune Neurobeachin Cerebellar Ataxia

Basal E, Gilligan M, Lesnick C, McKeon A.

Mov Disord. 2024 Dec;39(12):2271-2275. doi: 10.1002/mds.29991. Epub 2024 Aug 20.

Immune Checkpoint Inhibitor-Related Cerebellar Toxicity: Clinical Features and Comparison with Paraneoplastic Cerebellar Ataxia

Dentoni M, Florean I, Farina A, Joubert B, Do LD, Honnorat J, Damato V, Fabris M, Gigli GL, Valente M, Vogrig A.

Cerebellum. 2024 Dec;23(6):2308-2323. doi: 10.1007/s12311-024-01727-5. Epub 2024 Aug 17.

L-Carnitine in the Treatment of Psychiatric and Neurological Manifestations: A Systematic Review

Wang W, Pan D, Liu Q, Chen X, Wang S.

Nutrients. 2024 Apr 20;16(8):1232. doi: 10.3390/nu16081232.

Review of Opsoclonus-Myoclonus Ataxia Syndrome in Pediatric Patients

Hsu M, Tejani I, Shah N, Olaosebikan R, Kumar A, Naik S.

Children (Basel). 2024 Mar 19;11(3):367. doi: 10.3390/children11030367.

Chronic Immune Sensory Polyradiculopathy (CISP): A Systematic Review of the Literature

Singhal S, Khanna R, Surendranath A, Chhabra J, Thakkar V, Gupta R.

Neurol Int. 2024 Oct 25;16(6):1214-1222. doi: 10.3390/neurolint16060092.

Frequency, characteristics, and immunological accompaniments of ataxia in anti-NMDAR antibody-associated encephalitis

Jesse S, Riemann M, Schneider H, Ringelstein M, Melzer N, Vogel N, Pfeffer LK, Friese MA, Sühs KW, Hudasch D, Schwenkenbecher P, Günther A, Geis C, Wickel J, Lesser M, Kather A, Leypoldt F, Dargvainiene J, Markewitz R, Wandinger KP, Thaler FS, Kuchling J, Wurdack K, Sabater L, Finke C, Lewerenz J.

Front Immunol. 2024 Dec 13;15:1500904. doi: 10.3389/fimmu.2024.1500904. eCollection 2024.

Primary Coenzyme Q10 Deficiency-Related Ataxias

Lopriore P, Vista M, Tessa A, Giuntini M, Caldarazzo Ienco E, Mancuso M, Siciliano G, Santorelli FM, Orsucci D.

J Clin Med. 2024 Apr 19;13(8):2391. doi: 10.3390/jcm13082391.

Ataxia and Hypogonadism: a Review of the Associated Genes and Syndromes

De Michele G, Maione L, Cocozza S, Tranfa M, Pane C, Galatolo D, De Rosa A, De Michele G, Saccà F, Filla A.

Cerebellum. 2024 Apr;23(2):688-701. doi: 10.1007/s12311-023-01549-x. Epub 2023 Mar 30.

Association between cytomegalovirus infection and neurological disorders: A systematic review

Sanami S, Shamsabadi S, Dayhimi A, Pirhayati M, Ahmad S, Pirhayati A, Ajami M, Hemati S, Shirvani M, Alagha A, Abbarin D, Alizadeh A, Pazoki-Toroudi H.

Rev Med Virol. 2024 May;34(3):e2532. doi: 10.1002/rmv.2532.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias